Peli BioThermal, the global name in cold chain, providing the broadest and most innovative range of temperature-controlled packaging solutions serving the life sciences industry, will showcase its thermal shipper solutions at Clinical Trial Supply Nordics in Europe.
Experts from Peli BioThermal will share industry insight, knowledge on mitigating clinical trial supply chain risks and how to address the latest clinical trial challenges.
At the two-day conference, taking place in Copenhagen, Denmark from 7 – 8 June 2017, Peli BioThermal will be exhibiting their latest temperature-controlled packaging options, designed for the global transportation of pharmaceutical products.
Conference delegates will discuss industry issues including temperature maintenance challenges and examine balancing trial requirements and supply costs within the biologics supply chain.
Paul Terry, Peli BioThermal’s Director of Sales EMEA, said: “Clinical trials is an area of rapid growth for us and we are constantly responding to the increasing requirements in the global transportation of biologics and pharmaceutical products. “The Peli BioThermal team will share their knowledge with delegates highlighting how vital it is to utilise robust, reliable shipper solutions to mitigate risk and protect payloads to ensure clinical trial supply chain compliance.
“We have extensive expertise within the clinical trial supply industry and will be exhibiting our range of innovative, high-performing products specifically engineered to meet the stringent sector’s requirements and regulations, including our award-winning Chronos™ Advance.”
Peli BioThermal will be exhibiting its industry leading supply chain services and solutions at Stand 18 including:
• Award-winning Chronos™ Advance and Chronos™ Express, a range of high performance single-use shipping systems, utilising advanced insulation and phase change materials.
• Crēdo™ Cube a reusable thermal shipper that protect payload contents at defined temperatures longer than any other passive thermal shipper.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.